-
Je něco špatně v tomto záznamu ?
Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial
J. Žatecký, O. Kubala, O. Coufal, M. Kepičová, A. Faridová, K. Rauš, M. Lerch, M. Peteja, R. Brát
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
PubMed
34602944
DOI
10.1159/000510380
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Introduction: The aim of this study was to evaluate the accuracy and reliability of the Magseed magnetic marker in breast cancer surgery. Methods: Thirty-nine patients with 41 implanted Magseeds undergoing surgical treatment in 3 surgical oncology departments were included in the retrospective trial to study pilot use of the Magseed magnetic marker in the Czech Republic for localisation of breast tumours or pathological axillary nodes in breast cancer patients. Results: Thirty-four breast cancer and 7 pathological lymph node localisations were performed by Magseed implantation. No placement failures, or perioperative detection failures of Magseeds were observed (0/41, 0.0%), but one case of Magseed migration was present (1/41, 2.4%). All magnetic seeds were successfully retrieved (41/41, 100.0%). Negative margins were achieved in 29 of 34 (85.3%) breast tumour localisations by Magseed. Conclusion: Magseed is a reliable marker for breast tumour and pathological axillary node localisation in breast cancer patients. Magseed is comparable to conventional localisation methods in terms of oncosurgical radicality and safety.
Department of Surgery Silesian Hospital in Opava Opava Czechia
Department of Surgery University Hospital Ostrava Ostrava Czechia
Department of Surgical Oncology Faculty of Medicine Masaryk University Brno Czechia
Department of Surgical Oncology Masaryk Memorial Cancer Institute Brno Czechia
Department of Surgical Studies Faculty of Medicine University of Ostrava Ostrava Czechia
Oncogynecology Centre The Institute for the Care of Mother and Child Prague Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22001754
- 003
- CZ-PrNML
- 005
- 20220112153713.0
- 007
- ta
- 008
- 220107s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000510380 $2 doi
- 035 __
- $a (PubMed)34602944
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Žatecký, Jan $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czechia $u Department of Surgery, Silesian Hospital in Opava, Opava, Czechia
- 245 10
- $a Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial / $c J. Žatecký, O. Kubala, O. Coufal, M. Kepičová, A. Faridová, K. Rauš, M. Lerch, M. Peteja, R. Brát
- 520 9_
- $a Introduction: The aim of this study was to evaluate the accuracy and reliability of the Magseed magnetic marker in breast cancer surgery. Methods: Thirty-nine patients with 41 implanted Magseeds undergoing surgical treatment in 3 surgical oncology departments were included in the retrospective trial to study pilot use of the Magseed magnetic marker in the Czech Republic for localisation of breast tumours or pathological axillary nodes in breast cancer patients. Results: Thirty-four breast cancer and 7 pathological lymph node localisations were performed by Magseed implantation. No placement failures, or perioperative detection failures of Magseeds were observed (0/41, 0.0%), but one case of Magseed migration was present (1/41, 2.4%). All magnetic seeds were successfully retrieved (41/41, 100.0%). Negative margins were achieved in 29 of 34 (85.3%) breast tumour localisations by Magseed. Conclusion: Magseed is a reliable marker for breast tumour and pathological axillary node localisation in breast cancer patients. Magseed is comparable to conventional localisation methods in terms of oncosurgical radicality and safety.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kubala, Otakar $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czechia $u Department of Surgery, University Hospital Ostrava, Ostrava, Czechia
- 700 1_
- $a Coufal, Oldřich $u Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia $u Department of Surgical Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia
- 700 1_
- $a Kepičová, Markéta $u Department of Surgery, University Hospital Ostrava, Ostrava, Czechia
- 700 1_
- $a Faridová, Adéla $u Oncogynecology Centre, The Institute for the Care of Mother and Child, Prague, Czechia
- 700 1_
- $a Rauš, Karel $u Oncogynecology Centre, The Institute for the Care of Mother and Child, Prague, Czechia
- 700 1_
- $a Lerch, Milan $u Department of Surgery, Silesian Hospital in Opava, Opava, Czechia
- 700 1_
- $a Peteja, Matúš $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czechia $u Department of Surgery, Silesian Hospital in Opava, Opava, Czechia
- 700 1_
- $a Brát, Radim $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czechia
- 773 0_
- $w MED00173016 $t Breast care (Basel, Switzerland) $x 1661-3791 $g Roč. 16, č. 4 (2021), s. 383-388
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34602944 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220107 $b ABA008
- 991 __
- $a 20220112153709 $b ABA008
- 999 __
- $a ind $b bmc $g 1745604 $s 1152901
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 16 $c 4 $d 383-388 $e 20201014 $i 1661-3791 $m Breast care $n Breast Care (Basel) $x MED00173016
- LZP __
- $a Pubmed-20220107